Vancomycin prescribing practices in hospitalized chronic hemodialysis patients

American Journal of Kidney Diseases

Volumn 35, Issue 1, 2000, Pages 64-68

  Green, Kevin ^a   Schulman, Gerald ^a   Haas, David W ^a   Schaffner, William ^a   D'Agata, Erika M C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Chronic; Enterococcus; Hemodialysis; Hospital; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CATHETER INFECTION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; TREATMENT INDICATION;

EID: 0033960531     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70303-9     Document Type: Article

References (23)

1. JI Tokars ER Miller MJ Alter MJ Arduino National Surveillance of Dialysis-Associated Disease in the United States, 1996 1998 Public Health Service, Department of Health and Human Services Atlanta, GA 1 59
2. S Handwerger B Raucher D Altarac J Monka S Marchione KV Singh BE Murray J Wolff B Walters Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin Infect Dis 16 1993 750 755
3. B Ostrowski L Venkataraman E D'Agata H Gold P DeGirolami M Samore Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during non-outbreak periods Arch Intern Med 159 1999 1467 1472
4. MB Edmond JF Ober DL Weinbaum MA Pfaller T Hwang MD Sanford RP Wenzel Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection Clin Infect Dis 20 1995 1126 1133
5. KJ Henning H Delencastre J Eagan N Boone A Brown M Chung N Wollner D Armstrong Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection Pediatr Infect Dis J 15 1996 848 854
6. Hospital Infection Control Practices Advisory Committee Recommendations for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 16 1995 105 113
7. JS Garner WR Jarvis TG Emori TC Horan JM Hughes CDC definitions for nosocomial infections Am J Infect Control 16 1988 128 140
8. ML Pearson the Hospital Infection Control Practices Advisory Committee Guidelines for prevention of intravascular device-related infections Am J Infect Control 24 1996 262 293
9. PR Murray EJ Baron MA Pfaller FC Tenover RH Yolken Manual of Clinical Microbiology ed 6 1995 American Society for Microbiology Press Washington, DC 1327 1343
10. C Watanakunakorn Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci Infect Control Hosp Epidemiol 18 1997 767 769
11. MV Singer R Haft T Barlam M Aronson A Shafer K Sands Vancomycin control measures at a tertiary-care hospital: Impact of interventions on volume and patterns of use Infect Control Hosp Epidemiol 19 1998 248 253
12. SV Johnson LL Hoey K Vance-Bryan Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention Pharmacotherapy 15 1995 579 585
13. BA Logsdon KR Lee G Luedtke FF Barrett Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria Infect Control Hosp Epidemiol 18 1997 780 782
14. AM Anglim B Klym KE Byers WM Scheld BM Farr Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 157 1997 1132 1136
15. ME Evans KJ Kortas Vancomycin use in a university medical center: Comparison with hospital infection control practices advisory committee guidelines Infect Control Hosp Epidemiol 17 1996 356 359
16. Centers for Disease Prevention and Control Reduced susceptibility to Staphylococcus aureus to vancomycin—Japan, 1997 MMWR 46 1997 626
17. K Sieradzki RB Roberts SW Haber A Tomasz The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection N Engl J Med 340 1999 517 523
18. TL Smith ML Pearson KR Wilcox C Cruz MV Lancaster B Robinson-Dunn FC Tenover MJ Zervos JD Band E White WR Jarvis Emergence of vancomycin resistance in Staphylococcus aureus . Glycopeptide-Intermediate Staphylococcus aureus Working Group N Engl J Med 340 1999 493 501
19. O Korzeniowski MA Sande the National Collaborative Endocarditis Study Group Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non-addicts: A prospective study Ann Intern Med 97 1982 496 503
20. HF Chambers RT Miller MD Newman Two-week combination therapy of right-sided Staphylococcus aureus endocarditis in intravenous drug abusers Ann Intern Med 109 1988 619 624
21. AW Karchmer Staphylococcus aureus and vancomycin: The sequel Ann Intern Med 115 1991 739 740
22. PM Small HF Chambers Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users Antimicrob Agents Chemother 34 1990 1227 1231
23. CA Greenaway J Embil PH Orr J McLeod B Dyck LE Nicolle Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital Infect Control Hosp Epidemiol 18 1997 749 756